H
HBANZ
About this security
HBANZ is a 5.5% non-cumulative perpetual preferred stock issued by Huntington Bancshares Incorporated Depositary Shares Each Representing a 11000th Interest in a Share of 5.50 Series L NonCumulative Perpetual Preferred Stock. Current yield 6.89%.
Huntington Bancshares Incorporated Depositary Shares Each Representing a 11000th Interest in a Share of 5.50 Series L NonCumulative Perpetual Preferred Stock: Huntington Bancshares Incorporated (Nasdaq: HBAN) is a $285 billion regional bank holding company headquartered in Columbus, Ohio, whose principal subsidiary is The Huntington National Bank. Founded in 1866, the company provides banking, payments, wealth management, and risk management products and services to a broad range of customers, including consumers, small and middle-market businesses, corporations, and municipalities. Its offerings span deposits, lending, mortgage banking, dealer financing, investment management, trust, brokerage, insurance, equipment financing, asset-based lending, and distribution finance. ↗
Key Stats structural terms pending prospectus match
⚠ Liquidation preference not yet confirmed from the prospectus ("par pending"), so premium/discount and yield-to-call are withheld rather than computed from an assumed value. Price, yield, and dividends are exact from the market feed.
Quote
| HBANZ (preferred) | |
|---|---|
| Last | $19.97 |
| Change | -0.06 (-0.30%) |
| Open | $20.04 |
| High / Low | $20.04 / $19.97 |
| Prev Close | $20.03 |
| Volume | 1,186 |
| 52-Week High / Low | $22.23 / $19.91 |
52-week range based on available history. Shares outstanding / market cap require a fundamentals feed (not in current data plan).
Price
Dividend History
| Ex-Date | Amount / Share |
|---|---|
| 2026-04-30 | $0.343750 |
Performance
See what an investment would be worth today, dividends reinvested. Run the $10K calculator for HBANZ →
News — Huntington Bancshares Incorporated Depositary Shares Each Representing a 11000th Interest in a Share of 5.50 Series L NonCumulative Perpetual Preferred Stock
- Soleno Therapeutics Presents New VYKAT XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements in Hyperphagia and Behavioral Symptoms in Prader-Willi Syndrome Following Randomized Withdrawal Period — finance.yahoo.com · Jun 15, 2026
- Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026 — finance.yahoo.com · Jun 15, 2026
- HBAN Assumed by Stephens & Co. -- Rating Set to Equal-Weight — gurufocus.com · Jun 15, 2026
- Investment Analysts’ New Coverage for June 15th (BRAI, CFG, DD, ESE, FITB, HBAN, KDK, KEY, LCLN, PNC) — thelincolnianonline.com · Jun 15, 2026
- Automatic Data Processing And 2 Other Reliable Dividend Stocks To Consider — finance.yahoo.com · Jun 15, 2026
- Automatic Data Processing And 2 Other Reliable Dividend Stocks To Consider — simplywall.st · Jun 15, 2026
- Huntington Bancshares (HBAN) Coverage Initiated with Equal Weight Rating — gurufocus.com · Jun 15, 2026
- Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026 — finance.yahoo.com · Jun 15, 2026
Issuer news via Tiingo, tagged to HBAN.